INS and type 2 diabetes mellitus: Lankisch and colleagues recruited 393 people with Type 2 diabetes inadequately controlled by basal insulin glargine and oral anti-diabetic drugs, who were subsequently randomized to receive a single prandial injection of insulin glulisine for 24 weeks in addition to their existing regimen (insulin glargine plus oral anti-diabetic drugs) 20.